Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Li Kang Biomedical CoROCO:6242 81 Dividend Yield % is 5.56% as of Jul. 24, 2026, which is 8% above its 10-year median of 5.13. GuruFocus rates ROCO:6242 with a GF Score™ of 81/100 and a GF Value™ of NT$38.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 409 Travel & Leisure companies, Li Kang Biomedical Co ranks better than 80.68% on this metric.
As of today (2026-07-24), the Trailing Annual Dividend Yield of Li Kang Biomedical Co is 5.56%.
The historical rank and industry rank for Li Kang Biomedical Co's Dividend Yield % or its related term are showing as below:
ROCO:6242'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.1 Med: 5.13 Max: 9.2
Current: 5.56
During the past 13 years, the highest Dividend Yield of Li Kang Biomedical Co was 9.20%. The lowest was 0.10%. And the median was 5.13%.
ROCO:6242's Dividend Yield % is ranked better than 80.68% of 409
companies
in the Travel & Leisure industry
Industry Median: 2.79
vs ROCO:6242: 5.56
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Li Kang Biomedical Co Ltd is 0.76, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Li Kang Biomedical Co was 1.21. The lowest was 0.02. And the median was 0.69.
During the past 12 months, Li Kang Biomedical Co's average Dividends Per Share Growth Rate was -20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 16.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Li Kang Biomedical Co was 268.50% per year. The lowest was -14.30% per year. And the median was 6.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Li Kang Biomedical Co (ROCO:6242) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Li Kang Biomedical Co Dividend Yield % Related Terms
Li Kang Biomedical Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Li Kang Biomedical Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6242 vs BKNG, ABNB, RCL: Dividend Yield % Comparison
For the Travel Services subindustry, Li Kang Biomedical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Li Kang Biomedical Co Dividend Yield % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Li Kang Biomedical Co's Dividend Yield % falls into.
Li Kang Biomedical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Li Kang Biomedical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 2.000000
2026-06-16
2026-06-17
2026-07-22
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Li Kang Biomedical Co's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Li Kang Biomedical Co (ROCO:6242) has a Dividend Yield % of 5.56% as of Jul. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Li Kang Biomedical Co and its competitors. This is near median its historical median of 5.13. Over the past decade, Li Kang Biomedical Co's Dividend Yield % has ranged from 0.10 to 9.20. According to the industry distribution chart, Li Kang Biomedical Co ranks #79 out of 409 companies in the Travel & Leisure industry, placing it in the top 19.3%.
Is Li Kang Biomedical Co's Dividend Yield % too high?
Li Kang Biomedical Co's current Dividend Yield % of 5.56% is near median its 10-year median of 5.13. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 9.20. The Travel & Leisure industry median Dividend Yield % is 2.79. Li Kang Biomedical Co's value of 5.56% is 99.3% above this industry median. Based on the distribution chart, Li Kang Biomedical Co ranks #79 out of 409 companies in the Travel & Leisure industry, which is in the top quartile — a strong position relative to peers. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's Dividend Yield % compare to BKNG and ABNB?
According to the Travel & Leisure industry distribution chart, Li Kang Biomedical Co ranks #79 out of 409 companies for Dividend Yield %. This places Li Kang Biomedical Co in the top 19% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.79. Li Kang Biomedical Co's value of 5.56% is 99.3% above this benchmark. Historically, Li Kang Biomedical Co's own Dividend Yield % has ranged from 0.10 to 9.20 over the past decade. While the company's 10-year median is 5.13 vs. the industry median of 2.79, Li Kang Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Travel & Leisure company?
The median Dividend Yield % among Travel & Leisure companies is 2.79, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Li Kang Biomedical Co's current Dividend Yield % of 5.56% is 99.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Li Kang Biomedical Co and its competitors. For the Travel & Leisure industry, the median Dividend Yield % is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Li Kang Biomedical Co's current Dividend Yield % is 5.56%, which is near median its own 10-year median of 5.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Fairly Valued. The stock's GF Value™ is NT$38.97, compared to a current price of NT$35.95 — trading 7.7% below its estimated fair value. The current Dividend Yield % is 5.56%, which is near median its 10-year median of 5.13 and 99.3% above the Travel & Leisure industry median of 2.79. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current Dividend Yield % is 5.56% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?
Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued.
The current stock price of NT$35.95 is trading 7.7% below its estimated GF Value™ of NT$38.97.
GuruFocus considers Li Kang Biomedical Co to be Fairly Valued.
Key valuation signals for ROCO:6242:
Dividend Yield %: 5.56% (near median its 10-year median of 5.13)
GF Value™: NT$38.97 vs. price of NT$35.95 (7.7% below fair value)
Industry Position: 99.3% above the Travel & Leisure median (#79 of 409)
No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score
Get the complete analysis for ROCO:6242
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6242 has been successfully added to your 
